Skip to main content
. 2021 Sep;10(9):3948–3962. doi: 10.21037/tcr-21-929

Table 2. Univariate Cox regression model analysis for OS and CSS in nomogram cohort.

Characteristics Overall survival (OS) Cancer-specific survival (CSS)
HR (95% CI) P value HR (95% CI) P value
Age at diagnosis (years)
   <50 1 (reference) 1 (reference)
   50–64 0.945 (0.598–1.494) 0.808 1.024 (0.597–1.754) 0.932
   64–79 0.999 (0.638–1.563) 0.995 0.895 (0.522–1.533) 0.686
   ≥80 1.375 (0.839–2.253) 0.207 1.146 (0.625–2.104) 0.659
Sex
   Male 1 (reference) 1 (reference)
   Female 1.191 (0.899–1.578) 0.224 1.178 (0.835–1.660) 0.350
Race
   Caucasian 1 (reference) 1 (reference)
   African 1.323 (0.918–1.907) 0.133 1.370 (0.886–2.119) 0.157
   Other 1.067 (0.649–1.754) 0.797 0.994 (0.537–1.841) 0.986
Marital status
   Married 1 (reference) 1 (reference)
   Single 1.512 (1.161–1.970) 0.002 1.341 (0.972–1.850) 0.074
   Unknown 0.884 (0.509–1.534) 0.660 0.604 (0.280–1.302) 0.198
Primary site
   Trigone of bladder 1 (reference) 1 (reference)
   Dome of bladder 0.729 (0.359–1.479) 0.381 0.799 (0.315–2.027) 0.637
   Lateral wall of bladder 0.956 (0.496–1.841) 0.892 1.049 (0.445–2.476) 0.912
   Anterior wall of bladder 1.101 (0.396–3.060) 0.854 1.574 (0.473–5.234) 0.459
   Posterior wall of bladder 1.202 (0.597–2.420) 0.606 1.333 (0.536–3.318) 0.536
   Bladder neck 0.742 (0.299–1.842) 0.520 1.187 (0.411–3.426) 0.751
   Ureteric orifice 0.291 (0.037–2.287) 0.241 0.708 (0.088–5.675) 0.745
   Urachus 0.439 (0.168–1.145) 0.092 0.538 (0.162–1.789) 0.312
   Overlapping lesion of bladder 1.116 (0.601–2.071) 0.729 1.597 (0.727–3.506) 0.244
   Bladder, NOS 1.265 (0.726–2.205) 0.407 1.537 (0.742–3.183) 0.248
Grade
   II 1 (reference) 1 (reference)
   III 4.183 (1.031–16.972) 0.045 2.612 (0.643–10.608) 0.179
   IV 3.290 (0.799–13.552) 0.099 2.115 (0.510–8.764) 0.302
   Unknown 3.810 (0.924–15.712) 0.064 2.034 (0.485–8.530) 0.332
T stage
   Tis 0.347 (0.047–2.543) 0.298 0.001 (0.0001–2.520) 0.949
   T1 1 (reference) 1 (reference)
   T2 1.003 (0.650–1.548) 0.990 1.542 (0.854–2.787) 0.151
   T3 1.142 (0.723–1.803) 0.569 1.692 (0.912–3.136) 0.095
   T4 1.615 (1.076–2.425) 0.021 2.463 (1.405–4.138) 0.002
   Unknown 1.386 (0.778–2.471) 0.268 1.302 (0.552–3.072) 0.547
N stage
   N0 1 (reference) 1 (reference)
   N1 1.306 (0.909–1.877) 0.149 1.227 (0.784–1.921) 0.370
   N2 1.610 (1.145–2.264) 0.006 1.781 (1.202–2.637) 0.004
   N3 1.098 (0.272–4.440) 0.895 0.777 (0.108–5.578) 0.802
   Unknown 1.244 (0.741–2.087) 0.409 0.912 (0.443–1.877) 0.803
M stage
   M0 1 (reference) 1 (reference)
   M1 2.613 (1.939–3.521) <0.001 2.940 (2.076–4.163) <0.001
   Unknown 1.026 (0.524–2.008) 0.941 0.693 (0.255–1.879) 0.471
Surgery
   No surgery 1 (reference) 1 (reference)
   TURBT 0.662 (0.457–0.958) 0.029 1.055 (0.638–1.743) 0.836
   Partial cystectomy 0.271 (0.146–0.504) <0.001 0.320 (0.136–0.755) 0.009
   Radical cystectomy 0.433 (0.302–0.621) <0.001 0.701 (0.428–1.146) 0.157
   Other 0.781 (0.460–1.324) 0.359 1.118 (0.559–2.233) 0.753
Radiation
   No/unknown 1 (reference) 1 (reference)
   Yes 1.512 (1.110–2.059) 0.009 1.367 (0.931–2.007) 0.111
Chemotherapy
   No/unknown 1 (reference) 1 (reference)
   Yes 1.092 (0.846–1.410) 0.497 1.230 (0.903–1.675) 0.189
Size (cm)
   ≤5.5 1 (reference) 1 (reference)
   >5.5 2.390 (1.567–3.646) <0.001 2.714 (1.663–4.428) <0.001
   Unknown 1.864 (1.397–2.485) <0.001 1.795 (1.261–2.554) 0.001
LNR
   No LN removed 1 (reference) 1 (reference)
   More than one LN removed <0.001 0.007
    LNR =0 0.340 (0.226–0.510) <0.001 0.402 (0.250–0.647) <0.001
    ≤0.90 0.789 (0.569–1.094) 0.155 0.836 (0.564–1.238) 0.371
    >0.90 1.451 (0.737–2.857) 0.282 1.660 (0.767–3.594) 0.198
   Unknown 0.603 (0.326–1.115) 0.107 0.578 (0.268–1.249) 0.163

OS, overall survival; CSS, cancer-specific survival; HR, hazard ratio; CI, confidence interval; NOS, not otherwise specified; TURBT, transurethral resection of bladder tumor; LNR, lymph node ratio; LN, lymph node.